Ligand validation:3FQ0

N22: 5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine

N22 is a Ligand Of Interest in 3FQ0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3FQ0_N22_A_219	71%	26%	0.101	0.921	0.74	2.19	-	10	2	0	100%	1
3FQO_N22_A_219	82%	27%	0.098	0.953	0.76	2.12	1	8	2	0	100%	1
3I8A_N22_X_219	76%	20%	0.125	0.962	0.99	2.33	1	8	3	0	100%	1
3CSE_N22_B_302	88%	1%	0.078	0.953	2.97	4.72	16	17	2	0	100%	1
3E0B_N22_A_208	61%	18%	0.137	0.925	1.41	2.09	1	8	0	0	100%	1
3QLW_N22_B_194	56%	16%	0.168	0.941	1.56	2.15	5	9	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.